Provided By PR Newswire
Last update: Oct 14, 2025
AI tools will allow CalciMedica to analyze Phase 2 datasets to refine the target patient populations and efficacy endpoints for upcoming pivotal trials
Read more at prnewswire.comNASDAQ:CALC (11/7/2025, 8:00:02 PM)
3.04
-0.02 (-0.65%)
Find more stocks in the Stock Screener


